Dave chats with Renee Zuks, Daughter of a Hodgkin Lymphoma Patient
Renee’s explains her mother Rita Zuks was diagnosed with Hodgkin lymphoma in 2013 at the age of 60. Rita underwent surgery, chemotherapy and radiotherapy, only to have her cancer return as non-Hodgkin lymphoma two years later. This time Rita endured further chemotherapy and a stem cell transplant however the cancer returned a short time later. Having exhausted all treatment options Rita was given a second chance at life when she was referred to a clinical trial through Blood Cancer Research WA. In fact, Rita moved through 5 clinical trials each one providing her with extra time at life. Renee is so grateful to have had more quality time with her mum and that the treatments she received provided her with a good quality of life and precious memories for her family. Renee wants to help Snowdome raise funds for blood cancer research so other patients get the best opportunity for further life and a cure.
Every day, over 50 Australians are diagnosed with blood cancer making it the second deadliest cancer in Australia Clinical trials are vital in accelerating new therapies and yet less than 20% Australian blood cancer patients participate inclinical trials
This Blood Cancer Awareness Month, the Snowdome Foundation is calling for Aussies to raise funds and help
Blood cancer is our second deadliest cancer, with over fifty Australians diagnosed every day, more than a 6% increase on last year. This Blood Cancer Awareness Month, the Snowdome Foundation is highlighting the importance of funding clinical trials and how lifesaving they can be to those living with blood cancer.
A staggering 17,000 Australians were diagnosed with a blood cancer in 2020, with the number of deaths heartbreakingly reaching over 5,500 . This year, it is expected that 18,485 Australians will be newly diagnosed with blood cancer such as leukaemia, lymphoma and myeloma . These cancers can impact anyone regardless of age, health or gender and sadly, can’t be prevented. In fact, blood cancer remains the most common childhood cancer (0-14 years) accounting for over 45% of all diagnoses .
Research and clinical trials are monumental in uncovering new treatments which can extend the time a patient has with their loved ones, however less than 20% of blood cancer patients participate in clinical trials . With blood cancer diagnoses on the increase, gaining a greater understanding of blood cancers and accelerating next-generation therapies are crucial for Australian patients to live longer and more fulfilling lives.
This Blood Cancer Awareness Month, the Snowdome Foundation is encouraging Australians to get involved and kiss a vice goodbye for the month of September. Instead of indulging in your usual takeaway coffee or a cheeky block of chocolate, save these funds and make a donation to fund ground-breaking research into the nation’s second deadliest cancer.
Whilst there is currently no cure for blood cancer, research and clinical trials are the only way we will get closer to finding one – enabling patients to have more time with family, more experiences, and importantly to bank more memories.
To learn about future treatments and how to donate visit snowdome.org.au